Vertical Climbing (CLMBR) Exercise for Chronic Low Back Pain

Last updated: December 8, 2023
Sponsor: Icahn School of Medicine at Mount Sinai
Overall Status: Completed

Phase

N/A

Condition

Chronic Pain

Treatment

Recumbent cycling

Vertical climbing ergometer exercise

Clinical Study ID

NCT05483608
GCO 21-1568
  • Ages 18-64
  • All Genders

Study Summary

This is a randomized control trial of vertical climbing ergometer exercise for individuals with chronic low back pain. Using a parallel-arm design, participants will be randomized to 8 weeks of supervised exercise using either the vertical climbing ergometer (CLMBR) or a recumbent cycling ergometer. This feasibility study will examine the safety, tolerability, and efficacy of vertical climbing exercise for individuals with chronic low back pain.

Eligibility Criteria

Inclusion

Inclusion criteria:

  • Provision of signed and dated informed consent form
  • Stated willingness to comply with all study procedures and availability for theduration of the study
  • Confirmed chronic (>12 weeks) low back pain at screening assessment (based on patienthistory)
  • Ability to comply with the current Mount Sinai Health system COVID-19 requirements forresearch participants (e.g., vaccination, masks)

Exclusion

Exclusion criteria:

  • Criteria will be evaluated during the clinical evaluation at the screening visit. Alldeterminations will be the decision of the study physician:
  • Less than 2/10 low back pain on 0-10 numeric rating scale for average pain over past 7days at baseline assessment
  • Any cardiovascular or musculoskeletal contraindication to exercise
  • Impaired balance contraindicating exercise
  • Known psychological illnesses or cognitive impairments contraindicating exercise orpreventing the ability to complete study assessments
  • Current pregnancy
  • Current medications or new medications commenced that may impact the ability forchange to be detected in study
  • Any other contraindication in the opinion of the study physician

Study Design

Total Participants: 15
Treatment Group(s): 2
Primary Treatment: Recumbent cycling
Phase:
Study Start date:
November 08, 2022
Estimated Completion Date:
November 12, 2023

Connect with a study center

  • Mount Sinai Union Square

    New York, New York 10003
    United States

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.